Hao Liu

Mr. Hao Liu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Chromatography B
Verified
Journal Article
Closed access
HLHao Liu
Hao Liu
DWDong-Juan Wang
Dong-Juan Wang
KWKe-Xing Wan
Ke-Xing Wan
JZJuan Zhang
Juan Zhang
ZYZhao-Jian Yuan
Zhao-Jian Yuan
LZLin Zou
Lin Zou

9 October 2019 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
HLHao Liu
Hao Liu
JMJingkun Miao
Jingkun Miao
LZLin Zou
Lin Zou
KWKe-Xing Wan
Ke-Xing Wan
JZJuan Zhang
Juan Zhang
LZLin Zou
Lin Zou
Background: Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (mHS) deficiency is an autosomal recessive inborn error of metabolism, which will give rise to failure of ketogenesis in liver during illness or fasting. It is a very rare disease with only a few patients reported worldwide, most of which had a good prognosis after proper therapies. Case presentation: We report a 9-month-old boy with mHS deficiency presenting with unusually severe and persistent acidosis after diarrhea and reduced oral food intake. The metabolic acidosis persisted even after supplementation with sugar and alkaline solution. Blood purification and assisted respiration alleviated symptoms, but a second onset induced by respiratory infection several days later led to multiple organ failure and death. Urine organic acid analysis during the acute episode revealed a complex pattern of ketogenic dicarboxylic and 3-hydroxydicarboxylic aciduria with prominent elevation of glutaric acid and adipic acid, which seem to be specific to mHS deficiency. Plasma acylcarnitine analysis revealed elevated 3-hydroxybutyrylcarnitine and acetylcarnitine. This is the first report of elevated 3-hydroxybutyrylcarnitine in mHS deficiency. Whole exome sequencing revealed a novel compound heterozygous mutation in HMGCS2 (c.100C > T and c.1465delA). Conclusion: This severe case suggests the need for patients with mHS deficiency to avoid recurrent illness because it can induce severe metabolic crisis, possibly leading to death. Such patients may also require special treatment, such as blood purification. Urine organic acid profile during the acute episode may give a hint to the disease.

5 July 2017 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
HLHao Liu
Hao Liu
LHLingling Han
Lingling Han
JXJiayu Xie
Jiayu Xie
YWYingchao Wu
Yingchao Wu
YXYang Xie
Yang Xie
YZYumei Zhang
Yumei Zhang

28 September 2021 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
HLHao Liu
Hao Liu
JZJiang Zhu
Jiang Zhu
QLQiu Li
Qiu Li
DWDongjuan Wang
Dongjuan Wang
KWKexing Wan
Kexing Wan
JMJingkun Miao
Jingkun Miao

9 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYong Zhang
Yong Zhang
SYShi-Ying Yao
Shi-Ying Yao
JLJing Li
Jing Li
TYTingting Yu
Tingting Yu
HLHao Liu
Hao Liu
XZXiao-Long Zhou
Xiao-Long Zhou
Mitochondrial transfer RNA (mt-tRNA) modification determines organelle translation and function. GTPBP3 and MTO1 catalyze 5-taurinomethyluridine (τm5U) modification at wobble uridine of five mt-tRNAs. τm5U hypomodification causes mitochondrial encephalomyopathy, but the underlying pathogenesis and intervention strategy due to GTPBP3 mutations are lacking. In this study, we identify two genetic variants (c.689 A > C (p.Q230P) and c.1120 A > G (p.N374D)) of GTPBP3 in a Chinese proband with metabolic disorders and multisystem dysfunction. Mechanistically, Q230P and N374D mutations induce protein multimerization/aggregation, protease degradation, decreased GTPase activity, and tRNA modification to varying degrees, affecting mitochondrial translation, respiration, dynamics, and function. Homozygous N374D mutations in mice cause embryonic lethality; homozygous E230P or compound heterozygous E230P/N374D knock-in mice develop cardiac and muscular dysfunction due to altered mitochondrial translation. Mitochondrial dysfunction and pathology are efficiently reversed by virus-mediated GTPBP3 expression in cells and animals. This study provides valuable insights into the etiology of and promising intervention strategies for GTPBP3-related diseases.

1 August 2021 in Journal of Zhejiang University (Medical Sciences)
Verified
Journal Article
Open access
HLHao Liu
Hao Liu
CLChun Li
Chun Li
XLXiaowen Li
Xiaowen Li
LZLin Zou
Lin Zou
XHXiaoyan He
Xiaoyan He
JMJingkun Miao
Jingkun Miao
目的:分析Citrin蛋白缺陷引起的新生儿肝内胆汁淤积症(NICCD)患儿的临床特征及基因突变特点。方法:回顾性分析2012年9月至2017年12月于重庆医科大学附属儿童医院就诊的30例NICCD患儿和同期诊治的30例特发性新生儿胆汁淤积症(INC)患儿的临床表现、生化指标和目标基因捕获结合高通量测序并进行桑格-库森法(Sanger法)验证的结果。结果:NICCD与INC临床表现相似,但圆胖脸和陶土便在NICCD患儿中更为常见(均P<0.01)。与INC组比较,NICCD组血糖、前白蛋白、白蛋白、总蛋白、纤维蛋白原、转氨酶显著降低(P<0.05或P<0.01),而间接胆红素、碱性磷酸酶、乳酸脱氢酶、总胆汁酸、血脂、血氨、甲胎蛋白、凝血功能标志物均升高(P<0.05或P<0.01);INC组氨基酸水平多在正常值范围内,而NICCD组血液中瓜氨酸、甲硫氨酸、酪氨酸、精氨酸及苏氨酸的平均浓度均显著升高(均P<0.01);INC组尿有机酸轻度升高或完全正常,而NICCD组尿液中4-羟基苯乳酸、4-羟基苯丙酮酸及苯乳酸的浓度显著升高(均P<0.01)。NICCD组均存在SLC25A13突变,其中8例为纯合突变,9例为复合杂合突变,13例为单位点突变,以c.851_854del(53.19%)最常见,同时发现2个新的致病性突变c.1196T>A和c.919G>T。结论:对于新生儿肝内胆汁淤积症,并伴有圆胖脸、陶土便的患儿应警惕NICCD,血氨、甲胎蛋白、瓜氨酸、尿液4-羟基苯乳酸、4-羟基苯丙酮酸及苯乳酸显著升高可为临床诊断提供重要依据,目标基因捕获结合高通量测序技术对其诊断与鉴别诊断具有重要价值。